Edition:
United States

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

12.84USD
20 Apr 2018
Change (% chg)

$0.86 (+7.18%)
Prev Close
$11.98
Open
$12.10
Day's High
$12.94
Day's Low
$11.86
Volume
205,151
Avg. Vol
80,928
52-wk High
$16.61
52-wk Low
$7.21

Latest Key Developments (Source: Significant Developments)

Sientra Reports Qtrly Loss Per Share $0.92
Tuesday, 13 Mar 2018 04:01pm EDT 

March 13 (Reuters) - Sientra Inc ::SIENTRA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 SALES $11.1 MILLION VERSUS I/B/E/S VIEW $11.6 MILLION.REMAINS ON TRACK FOR FULL AND FINAL FDA APPROVAL FOR U.S. MANUFACTURED IMPLANTS.QTRLY LOSS PER SHARE $0.92.Q4 EARNINGS PER SHARE VIEW $-0.70, REVENUE VIEW $11.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Sientra Says Co Enters Into Agreement With Stifel, Nicolaus & Co Inc
Tuesday, 20 Feb 2018 05:15pm EST 

Feb 20 (Reuters) - Sientra Inc ::SIENTRA SAYS CO ENTERED INTO AGREEMENT WITH STIFEL, NICOLAUS & CO INC, TO SELL SHARES OF STOCK HAVING AN OFFERING PRICE OF UP TO $50 MILLION- SEC FILING.  Full Article

Sientra Announces Preliminary Unaudited Q4 Revenue
Monday, 8 Jan 2018 08:00am EST 

Jan 8 (Reuters) - Sientra Inc ::SIENTRA ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER 2017 REVENUE.SEES Q4 2017 REVENUE ABOUT $11.4 MILLION.Q4 REVENUE VIEW $11.8 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Sientra Inc Files For Mixed Shelf Of Upto $150 Million
Monday, 8 Jan 2018 06:20am EST 

Jan 8 (Reuters) - Sientra Inc ::SIENTRA INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING.  Full Article

Sientra posts qtrly loss of $0.74​ per share
Tuesday, 7 Nov 2017 04:01pm EST 

Nov 7 (Reuters) - Sientra Inc :Sientra reports third quarter 2017 financial results.Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016​.Qtrly ‍basic and diluted net loss per share attributable to common stockholders $0.74​.Net cash and cash equivalents as of September 30, 2017 were $37.6 million compared to $55.5 million at end of Q2 2017​.  Full Article

Sientra reports Q2 net loss per share attributable to stockholders $1.07​
Wednesday, 9 Aug 2017 04:01pm EDT 

Aug 10 (Reuters) - Sientra Inc -:Sientra® reports second quarter 2017 financial results.Q2 sales $8.2 million versus I/B/E/S view $7 million.Sientra Inc qtrly ‍basic and diluted net loss per share attributable to common stockholders $1.07​.  Full Article

Sientra, Silimed reach settlement of lawsuit and related arbitration
Tuesday, 1 Aug 2017 09:16am EDT 

Aug 1 (Reuters) - Sientra Inc ::Sientra says on June 27, co, Silimed Ind*A De Implantes Ltda reached settlement of lawsuit and related arbitration between them - SEC filing.Sientra says co agreed to pay Silimed lump sum of $9 million within 30-days of execution of settlement agreement, $1 million on or by July 1, 2018-SEC filing.Sientra Inc - company and Silimed have granted each other covenants not to sue with respect to certain specified conduct.Sientra Inc - parties executed settlement agreement on July 27, 2017.Sientra - should co enter international markets, has agreed to make royalty payments of $12.50 on net sales of certain breast implant specifications, up to $5 million.  Full Article

Sientra says settles lawsuit
Tuesday, 1 Aug 2017 08:30am EDT 

Aug 1 (Reuters) - Sientra Inc :Sientra announces settlement of lawsuit.Sientra - has entered into settlement agreement regarding mutual ip ownership and contract disputes with Silimed-Indústria De Implantes Ltda.  Full Article

Sientra Inc says amendment permits merger to be effected as a "short-form" merger‍​
Monday, 26 Jun 2017 06:25am EDT 

June 26 (Reuters) - Sientra Inc :Sientra Inc - co, Desert Acquisition Corp and Miramar Labs Inc. Entered into amendment no. 1 to agreement and plan of merger.Sientra Inc - the amendment permits the merger to be effected as a “short-form” merger‍​.Sientra Inc - amendment grants to co's unit right to buy from Miramar newly issued shares at a price equal to offer price- sec filing.  Full Article

Sientra to acquire Miramar labs for $20 million​
Monday, 12 Jun 2017 08:00am EDT 

June 12 (Reuters) - Sientra Inc :Sientra to acquire Miramar labs.‍sientra intends to secure a $50 million credit facility​.Keith Sullivan joins Sientra as strategic advisor.Sientra has agreed to acquire Miramar for an aggregate transaction value of $20 million​.Deal includes contractual rights for potential contingent payments of up to $14 million in cash upon achievement of certain milestones.Expect transaction to be meaningfully accretive to full year 2018 revenues.Transaction is not subject to a financing condition.Co has sufficient cash on hand to finance transaction.Co has also signed a term sheet with midcap financial services and silicon valley bank for a $50 million credit facility.Deal contemplates offer price of $0.3149/share plus right to get 1 or more contingent payments of up to about $0.7058/share on certain milestones ​.Subject to execution of definitive agreements, credit facility to be comprised of $40 million in term debt and a $10 million revolver.New credit facility is intended to replace Sientra's existing $20 million credit facility announced in march of 2017.  Full Article

BRIEF-Sientra Receives FDA Approval Of PMA Supplement

* SIENTRA INC - ADDITIONAL $10 MILLION OF EXISTING CREDIT FACILITY NOW ACCESSIBLE WITH FDA APPROVAL